Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Clin Exp Rheumatol ; 18(4): 523-4, 2000.
Article in English | MEDLINE | ID: mdl-10949734

ABSTRACT

Herein we report the first case of primary aspergillosis of the larynx in a patient with Felty's syndrome. A 53-year-old man, a florist by profession, with a 12-year history of rheumatoid arthritis and on treatment with steroids, was admitted because of hoarseness, and intermittent fever of 2 weeks' duration. On admission, physical examination and laboratory data showed, among other findings, splenomegalia and neutropenia. At bone marrow examination, normal cellularity with mild dyserythropoiesis was observed. A fiberoptic laryngoscopy showed white plaques on both the true vocal cords. Both culture and microscopic examination of these lesions provided the diagnosis of invasive process by Aspergillus flavus. A computed tomography of the middle ears, paranasal sinuses, and chest was normal. Thus, primary aspergillosis of the larynx and Felty's syndrome was diagnosed, and the patient was successfully treated with granulocyte colony-stimulating factor and systemic antifungal agents. Felty's syndrome, corticosteroid use, and occupational risk probably rendered our patient susceptible to Aspergillus infection.


Subject(s)
Aspergillosis/diagnosis , Aspergillus flavus , Felty Syndrome/microbiology , Larynx/microbiology , Adrenal Cortex Hormones/adverse effects , Adult , Aspergillosis/complications , Felty Syndrome/drug therapy , Humans , Male , Neutropenia/microbiology
2.
J Rheumatol ; 22(6): 1179-82, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7545756

ABSTRACT

Recombinant myeloid growth factors have been increasingly used in recent years to combat induced and disease associated neutropenia. Their application in the management of Felty's syndrome with intercurrent infection has raised concern that resultant neutrophilia and activation of a diverse array of polymorphonuclear cell functions may have an adverse effect on the rheumatoid disease process. We describe a patient with Felty's syndrome receiving short term treatment with recombinant human granulocyte colony stimulating factor (GCSF), who then developed acute renal failure in conjunction with leukocytoclastic vasculitis and presumptive gout. We address the issue of "adding fuel to the fire" and review reported implications of GCSF in induction of vasculitis.


Subject(s)
Bacterial Infections/drug therapy , Felty Syndrome/microbiology , Granulocyte Colony-Stimulating Factor/adverse effects , Leukopenia/drug therapy , Vasculitis, Leukocytoclastic, Cutaneous/etiology , Acute Kidney Injury/etiology , Felty Syndrome/complications , Gout/etiology , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Male , Middle Aged , Recombinant Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...